Irene Bissoli

Dr. Irene Bissoli

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VPVeronica Panichi
Veronica Panichi
IBIrene Bissoli
Irene Bissoli
SDStefania D'Adamo
Stefania D'Adamo
FFFlavio Flamigni
Flavio Flamigni
SCSilvia Cetrullo
Silvia Cetrullo
RBRosa Maria Borzì
Rosa Maria Borzì
Osteoarthritis (OA) is the most common joint disease, but no effective and safe disease-modifying treatment is available. Risk factors such as age, sex, genetics, injuries and obesity can concur to the onset of the disease, variably triggering the loss of maturational arrest of chondrocytes further sustained by oxidative stress, inflammation and catabolism. Different types of nutraceuticals have been studied for their anti-oxidative and anti-inflammatory properties. Olive-derived polyphenols draw particular interest due to their ability to dampen the activation of pivotal signaling pathways in OA. Our study aims to investigate the effects of oleuropein (OE) and hydroxytyrosol (HT) in in vitro OA models and elucidate their possible effects on NOTCH1, a novel therapeutic target for OA. Chondrocytes were cultured and exposed to lipopolysaccharide (LPS). Detailed analysis was carried out about the OE/HT mitigating effects on the release of ROS (DCHF-DA), the increased gene expression of catabolic and inflammatory markers (real time RT-PCR), the release of MMP-13 (ELISA and Western blot) and the activation of underlying signaling pathways (Western blot). Our findings show that HT/OE efficiently attenuates LPS-induced effects by firstly reducing the activation of JNK and of the NOTCH1 pathway downstream. In conclusion, our study provides molecular bases supporting the dietary supplementation of olive-derived polyphenols to revert/delay the progression of OA.

26 April 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
VPVeronica Panichi
Veronica Panichi
PDPaolo Dolzani
Paolo Dolzani
LCLuca Cattini
Luca Cattini
FAFrancesco Alabiso
Francesco Alabiso
IBIrene Bissoli
Irene Bissoli
RBRosa Maria Borzì
Rosa Maria Borzì

23 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
FAFrancesco Alabiso
Francesco Alabiso
ACAleksandra Seragnoli Chystyakova
Aleksandra Seragnoli Chystyakova
CCCristina Cosentino
Cristina Cosentino
IBIrene Bissoli
Irene Bissoli
VMVeronique Menoud
Veronique Menoud
SDStefania D'Adamo
Stefania D'Adamo
Objective: Transfer RNA-derived fragments (tRFs) belong to an emerging class of small non-coding RNAs that dynamically respond to metabolic stressors and drive different pathological processes, yet their role in osteoarthritis (OA) remains poorly explored. We aimed to define the tRF landscape in OA and investigate the function of 3’tRF Asp(GTC) in chondrocyte stress adaptation and translational control. Methods: Ex vivo , cartilage specimens from OA patients (n=6) and healthy donors (n=7) were analyzed by small RNA sequencing to define disease-associated tRF signatures. In vitro , primary chondrocytes derived from OA patients were treated with lipopolysaccharide (LPS) to mimic inflammatory environment of OA, used for small RNA sequencing (n=3) and validation analysis (n=6). Functional studies in C28/I2 chondrocytes included antisense oligonucleotide-mediated 3’tRF Asp(GTC) inhibition, AGO2-RNA immunoprecipitation (RIP), polysome profiling, stress granule (SG) immunofluorescence, and differential protein analysis. Computational target prediction and pathway enrichment were used to explore tRF-mediated regulatory networks. Results: Both OA cartilage and LPS-treated chondrocytes displayed upregulation of 3’tRF Asp(GTC) and 5’tRF Glu(CTC) , indicating a shared inflammatory tRF signature. Predicted targets of upregulated tRFs were enriched in stress-adaptive, proteostasis, and translational control pathways, whereas downregulated tRFs modulated mitochondrial processes. Silencing 3’tRF Asp(GTC) inhibited LPS-induced COX2 and MMP13 expression, prevented ER stress, and blocked SG assembly. RIP confirmed selective recruitment of 3’tRF Asp(GTC) into AGO2 complexes. Polysome profiling revealed association with 40S ribosomal subunit, mediating translational arrest and influencing selective mRNA expression. Conclusion: 3’tRF Asp(GTC) emerges as a regulator linking inflammation to translational control and SG dynamics in OA. tRFs thus could represent novel therapeutic targets in OA disease.